A new pancreatic cancer pill may be a game changer for patients
Daraxonrasib, which nearly doubled patients' survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.
Daraxonrasib, which nearly doubled patients' survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.
We summarize the week's scientific breakthroughs every Thursday.
An ocean current called the Atlantic Meridional Overturning Circulation will weaken by 50 percent by 2100. The question is what to do about it.